Hedge funds and institutional investors hold 86.99% of The Cigna Group's stock. The company, which provides insurance and health services, recently saw its price target lowered by Barclays to $339, indicating a potential upside of 20.03%. Analysts maintain a "Buy" rating, with an average target of $390.14, despite a recent earnings miss.